Cerebain Biotech Corp | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Cerebain Biotech Corp | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Cerebain Biotech Corp | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Cerebain Biotech Corp | 4: Statement of changes in beneficial ownership of securities
Cerebain Biotech Corp | 4: Statement of changes in beneficial ownership of securities
Cerebain Biotech Corp | 4: Statement of changes in beneficial ownership of securities
Cerebain Biotech Corp | 4: Statement of changes in beneficial ownership of securities
Cerebain Biotech Corp | 4: Statement of changes in beneficial ownership of securities
Cerebain Biotech Corp | 4: Statement of changes in beneficial ownership of securities
Cerebain Biotech Corp | SC 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities (Amendment)
Cerebain Biotech Corp | 4: Statement of changes in beneficial ownership of securities
Cerebain Biotech Corp | 4: Statement of changes in beneficial ownership of securities
Cerebain Biotech Corp | 3: Initial statement of beneficial ownership of securities
Cerebain Biotech Corp | 3: Initial statement of beneficial ownership of securities
Cerebain Biotech Corp | 4: Statement of changes in beneficial ownership of securities
Cerebain Biotech Corp | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities
Cerebain Biotech Corp | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities
Cerebain Biotech Corp | 3: Initial statement of beneficial ownership of securities
Cerebain Biotech Corp | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities
Cerebain Biotech Corp | 3: Initial statement of beneficial ownership of securities
No Data
No Data